Popovtzer Aron, Eisbruch Avraham
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109-0010, USA.
Expert Rev Anticancer Ther. 2008 Apr;8(4):633-44. doi: 10.1586/14737140.8.4.633.
Head and neck cancer is the fifth most common cancer in the USA. Although there have been major improvements in surgical and radiation techniques, the overall survival has not changed significantly in the last decade. The major changes occurring in recent years have been in the ability to preserve organs and to improve quality of life. The advances in radiation therapy include 3D conformal radiotherapy, intensity-modulated radiotherapy and, more recently, imaging-guided radiotherapy. In advanced head and neck cancer the addition of chemotherapy to radiation has concomitantly improved survival and facilitated higher rates of organ preservation. Clinical trials are needed to develop better strategies customized to subgroups defined by individual biological risk and imaging findings.
头颈癌是美国第五大常见癌症。尽管手术和放疗技术有了重大进步,但过去十年总体生存率并未显著改变。近年来发生的主要变化在于器官保留能力和生活质量的改善。放射治疗的进展包括三维适形放疗、调强放疗,以及最近的影像引导放疗。在晚期头颈癌中,放疗联合化疗可同时提高生存率并促进更高的器官保留率。需要开展临床试验,以制定更适合根据个体生物学风险和影像学检查结果定义的亚组的更好策略。